therefore, realizing downregulation of PIK3CA and ABCB1 by knocking out CDK6 in MDR cancer cells overexpressing ABCB1 might benefit combined chemotherapy against cancer cells with ABCB1-mediated MDR. Here, CDK6 is linked to cancer.